1. Oral Administration of Prunella vulgaris L Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects
   Jixue Zhao et al, 2018, Front. Pharmacol. CrossRef
2. Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer
   Yu-Lian Chen et al, 2020, Cancers CrossRef
3. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
   Fabian Baltes et al, 2020, IJMS CrossRef
4. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.
   Ferdinando Nicoletti, 0 CrossRef
5. Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
   Coralie Reger de Moura et al, 2020, Front. Oncol. CrossRef
6. Tumor DDR1 deficiency reduces liver metastasis by colon carcinoma and impairs stromal reaction
   Irene Romayor et al, 2021, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
7. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
   Li Chen et al, 2021, Front. Cell Dev. Biol. CrossRef
8. Network controllability solutions for computational drug repurposing using genetic algorithms
   Victor-Bogdan Popescu et al, 2022, Sci Rep CrossRef
9. Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma
   Linghong Wu et al, 2022, IJGM CrossRef
10. Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib
    Myles Vigoda et al, 2022, Cancer Biology & Therapy CrossRef
11. Evaluation of t-DARPP Expression Alteration in Association with DDR1 Expression in Non-Small Cell Lung Cancer
    Zahra Damavandi et al, 2024, IBJ CrossRef